Brief: Optinose Announces XHANCE Significantly Reduced Incidence Of Exacerbations For Patients With Chronic Sinusitis In Landmark Reopen Program
13/07/2022 13:13
July 13 (Reuters) - OptiNose Inc OPTN.O :
* OPTINOSE ANNOUNCES THAT XHANCE SIGNIFICANTLY REDUCED
INCIDENCE
OF EXACERBATIONS FOR PATIENTS WITH CHRONIC SINUSITIS IN LANDMARK
REOPEN PROGRAM
Source text for Eikon: ID:nGNXbxh10t
Further company coverage: OPTN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on OptiNose
See all newsOptiNose Inc reports results for the quarter ended March 31 - Earnings Summary
OptiNose Inc expected to post a loss of 74 cents a share - Earnings Preview
Brief: OptiNose Q4 Income From Operations USD 354 Thousand
U.S. RESEARCH ROUNDUP-Darden Restaurants, Nike, Optinose
U.S. STOCKS ON THE MOVE-Accenture, Nike, FedEx